Novo Nordisk | NVO - Debitur Perdagangan

Harga Saham
37.08
Perubahan Harian
-0.40 -1.07%
Bulanan
-21.81%
Tahunan
-52.89%
Q1 Perkiraan
35.99




Debitur Perdagangan Perubahan Tanggal
ANI Pharmaceuticals USD 281.08M 28.46M 2025-12
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Bausch Health Companies USD 2.35B 66M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Canopy Growth CAD 26.86M 23.17M 2025-09
Corcept Therapeutics USD 59.79M 9.84M 2025-12
Drreddys Laboratories INR 1.41B 11.6M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
GlaxoSmithKline GBP 7.76B 545M 2025-12
Merck USD 12.12B 596M 2025-09
Nektar Therapeutics USD 0 2.9M 2024-09
Novartis USD 8.98B 192M 2025-09
Novo Nordisk DKK 95.05B 2.4B 2025-12
Novo Nordisk DKK 14.27B 72.1B 2025-06
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 190.46M 8.54M 2025-12
Sanofi EUR 397M 100M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Zoetis USD 1.59B 49M 2025-12